Natalie Vena

2.3k total citations
16 papers, 1.0k citations indexed

About

Natalie Vena is a scholar working on Molecular Biology, Genetics and Nephrology. According to data from OpenAlex, Natalie Vena has authored 16 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Genetics and 4 papers in Nephrology. Recurrent topics in Natalie Vena's work include Renal Diseases and Glomerulopathies (4 papers), Genomics and Rare Diseases (3 papers) and Glioma Diagnosis and Treatment (3 papers). Natalie Vena is often cited by papers focused on Renal Diseases and Glomerulopathies (4 papers), Genomics and Rare Diseases (3 papers) and Glioma Diagnosis and Treatment (3 papers). Natalie Vena collaborates with scholars based in United States, Italy and Australia. Natalie Vena's co-authors include Azra H. Ligon, Keith L. Ligon, Sandro Santagata, Andrew J. Wagner, Izabela Malinowska-Kołodziej, Wei Qin, George D. Demetri, David J. Kwiatkowski, Nikhil H. Ramaiya and Robert G. Maki and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Natalie Vena

15 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Natalie Vena United States 11 414 393 374 289 167 16 1.0k
Davide Nicoli Italy 23 444 1.1× 377 1.0× 228 0.6× 200 0.7× 139 0.8× 72 1.4k
Paolo Cotzia United States 17 439 1.1× 364 0.9× 363 1.0× 99 0.3× 272 1.6× 34 1.1k
Massimo Brisigotti Italy 20 326 0.8× 488 1.2× 232 0.6× 233 0.8× 146 0.9× 55 1.4k
Markus Tiemann Germany 17 237 0.6× 177 0.5× 407 1.1× 83 0.3× 84 0.5× 73 959
Alice Parisi Italy 21 240 0.6× 330 0.8× 492 1.3× 91 0.3× 143 0.9× 45 1.2k
Shuangping Guo China 16 189 0.5× 382 1.0× 188 0.5× 65 0.2× 169 1.0× 50 855
Rüediger Liersch Germany 18 145 0.4× 438 1.1× 332 0.9× 84 0.3× 216 1.3× 33 942
Sara Cresta Italy 20 461 1.1× 422 1.1× 597 1.6× 83 0.3× 193 1.2× 55 1.3k
Linda N. Dao United States 10 125 0.3× 208 0.5× 251 0.7× 90 0.3× 67 0.4× 29 723
Sheng Xiao United States 9 794 1.9× 404 1.0× 322 0.9× 167 0.6× 108 0.6× 24 1.8k

Countries citing papers authored by Natalie Vena

Since Specialization
Citations

This map shows the geographic impact of Natalie Vena's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Natalie Vena with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Natalie Vena more than expected).

Fields of papers citing papers by Natalie Vena

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Natalie Vena. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Natalie Vena. The network helps show where Natalie Vena may publish in the future.

Co-authorship network of co-authors of Natalie Vena

This figure shows the co-authorship network connecting the top 25 collaborators of Natalie Vena. A scholar is included among the top collaborators of Natalie Vena based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Natalie Vena. Natalie Vena is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Lynch, Lauren, Patrick R. Shea, Natalie Vena, et al.. (2025). Genetic contributors to osteoporosis in pregnancy and lactation associated osteoporosis (PLO). Bone. 204. 117744–117744.
2.
Vena, Natalie, et al.. (2025). The Art and Science of Genetic Counseling in Nephrology. Kidney360. 6(7). 1230–1244. 1 indexed citations
3.
Elefant, Naama, Natalie Vena, Jun Y. Zhang, et al.. (2024). Developing a genetic testing panel for evaluation of morbidities in kidney transplant recipients. Kidney International. 106(1). 115–125. 7 indexed citations
4.
Elliott, Mark, Maddalena Marasà, Enrico Cocchi, et al.. (2023). Clinical and Genetic Characteristics of CKD Patients with High-Risk APOL1 Genotypes. Journal of the American Society of Nephrology. 34(5). 909–919. 10 indexed citations
5.
Batal, Ibrahim, Samih H. Nasr, Surendra Dasari, et al.. (2023). Pathologic-genomic correlation identified a novel variant in FN1 and established the diagnosis of recurrent fibronectin glomerulopathy in the kidney allograft. American Journal of Transplantation. 24(3). 498–502. 3 indexed citations
6.
Vena, Natalie, Hila Milo Rasouly, Maddalena Marasà, et al.. (2022). Incorporating genetics services into adult kidney disease care. American Journal of Medical Genetics Part C Seminars in Medical Genetics. 190(3). 289–301. 13 indexed citations
7.
Lippa, Natalie, Louise Bier, Anya Revah‐Politi, et al.. (2022). Diagnostic sequencing to support genetically stratified medicine in a tertiary care setting. Genetics in Medicine. 24(4). 862–869. 3 indexed citations
8.
Karst, Alison M., Natalie Vena, Azra H. Ligon, et al.. (2013). Cyclin E1 Deregulation Occurs Early in Secretory Cell Transformation to Promote Formation of Fallopian Tube–Derived High-Grade Serous Ovarian Cancers. Cancer Research. 74(4). 1141–1152. 132 indexed citations
9.
Craig, Justin M., Natalie Vena, Shakti Ramkissoon, et al.. (2012). DNA Fragmentation Simulation Method (FSM) and Fragment Size Matching Improve aCGH Performance of FFPE Tissues. PLoS ONE. 7(6). e38881–e38881. 20 indexed citations
10.
Rodríguez, Fausto J., Azra H. Ligon, Iren Horkayne‐Szakaly, et al.. (2012). BRAFDuplications and MAPK Pathway Activation Are Frequent in Gliomas of the Optic Nerve Proper. Journal of Neuropathology & Experimental Neurology. 71(9). 789–795. 48 indexed citations
11.
Rich, Benjamin E., Natalie Vena, Justin M. Craig, et al.. (2011). Detection of KIAA1549-BRAF Fusion Transcripts in Formalin-Fixed Paraffin-Embedded Pediatric Low-Grade Gliomas. Journal of Molecular Diagnostics. 13(6). 669–677. 64 indexed citations
12.
Dias‐Santagata, Dora, Quynh Lam, Natalie Vena, et al.. (2011). BRAF V600E Mutations Are Common in Pleomorphic Xanthoastrocytoma: Diagnostic and Therapeutic Implications. PLoS ONE. 6(3). e17948–e17948. 218 indexed citations
13.
Benedettini, Elisa, Lynette M. Sholl, Michael Peyton, et al.. (2010). Met Activation in Non-Small Cell Lung Cancer Is Associated with de Novo Resistance to EGFR Inhibitors and the Development of Brain Metastasis. American Journal Of Pathology. 177(1). 415–423. 139 indexed citations
14.
Priolo, Carmen, Michelle Agostini, Natalie Vena, et al.. (2010). Establishment and Genomic Characterization of Mouse Xenografts of Human Primary Prostate Tumors. American Journal Of Pathology. 176(4). 1901–1913. 44 indexed citations
15.
Clauss, Adam, Joyce F. Liu, Huiying Piao, et al.. (2010). Overexpression of Elafin in Ovarian Carcinoma Is Driven by Genomic Gains and Activation of the Nuclear Factor κB Pathway and Is Associated with Poor Overall Survival. Neoplasia. 12(2). 161–IN15. 55 indexed citations
16.
Wagner, Andrew J., Izabela Malinowska-Kołodziej, Jeffrey A. Morgan, et al.. (2010). Clinical Activity of mTOR Inhibition With Sirolimus in Malignant Perivascular Epithelioid Cell Tumors: Targeting the Pathogenic Activation of mTORC1 in Tumors. Journal of Clinical Oncology. 28(5). 835–840. 268 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026